Profile
Cross-Border Impact Ventures is an impact venture capital firm headquartered in Toronto, Canada. Founded by Annie Theriault, a notable leader in transformative health technology investments, the firm consists of experts specializing in women, children, and adolescent health. Distinguished for its mission to address health inequalities, it offers a hands-on approach to support management teams with market access and expertise in North America, Europe, and beyond.
The firm focuses on sectors like sexual and reproductive health, maternal and newborn health, and health software infrastructure, emphasizing gender and diversity lenses. It invests in globally relevant medical devices, diagnostics, therapeutics, and digital health innovations, targeting companies addressing gender health inequalities. With a total AUM unknown, the Women’s and Children’s Health Technology Fund II: $58 million (vintage August 2026) builds on prior success.
Notable investments include companies harnessing cutting-edge health technologies, but specific company names remain undisclosed. The firm seeks high-impact and high-return opportunities, committed to revolutionizing health technology venture investing.
Industry
CBIV Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Women's Health Tech Fund II
|
Venture Capital (VC)
|
HealthTech
Femtech
|
Seed
Series A
Series B
Late Stage (Series C+)
|
North America
Europe
Asia
|
$10-50 m
|
$58 M
|
August 2026
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.